CSPC Innovation Pharmaceutical financials at a glance
| Year | Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
1.26B | 1.32B | 1.43B | 0.00M | 2.50B | 0.00M |
| GM % | Gross Margin % |
|
51.19% | 55.60% | 47.81% | 0.00% | 45.28% | 0.00% |
| OM | Operating Margin |
|
22.74% | 24.83% | 23.66% | 0.00% | 30.95% | 0.00% |
| EPS | Earnings Per Share |
|
0.66 | 0.64 | 0.00 | |||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.08 | 0.32 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 12.12% | 50.00% | 0 |
| Sha. | Shares |
|
420m | 0m | 420m | 546m | 0m | 1170.74m |
| OCF | Operating Cash Flow |
|
315.38M | 349.07M | 170.59M | 0.00M | 927.24M | 0.00M |
| FCF | Free Cash Flow |
|
209.28M | 231.33M | 103.67M | 0.00M | 375.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
0.53 | 0.42 | 0.19 | 0.00 | 0.72 | 0.00 |